
Charles E. Cooley
Examiner (ID: 18400, Phone: (571)272-1139 , Office: P/1774 )
| Most Active Art Unit | 1774 |
| Art Unit(s) | 1797, 1774, 1723, 2402, 1754, 3405 |
| Total Applications | 4063 |
| Issued Applications | 3143 |
| Pending Applications | 300 |
| Abandoned Applications | 659 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9895092
[patent_doc_number] => 20150050291
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-19
[patent_title] => 'DETECTION AND MODULATION OF RHEUMATOID ARTHRITIS'
[patent_app_type] => utility
[patent_app_number] => 14/386597
[patent_app_country] => US
[patent_app_date] => 2013-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3970
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14386597
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/386597 | DETECTION AND MODULATION OF RHEUMATOID ARTHRITIS | Mar 18, 2013 | Abandoned |
Array
(
[id] => 9930913
[patent_doc_number] => 20150079105
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-19
[patent_title] => 'TREATMENT OF ACUTE INFLAMMATION IN THE RESPIRATORY TRACT'
[patent_app_type] => utility
[patent_app_number] => 14/389718
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 13266
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14389718
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/389718 | TREATMENT OF ACUTE INFLAMMATION IN THE RESPIRATORY TRACT | Mar 14, 2013 | Abandoned |
Array
(
[id] => 10038235
[patent_doc_number] => 09078931
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-07-14
[patent_title] => 'Antibody drug conjugates (ADC) that bind to 191P4D12 proteins'
[patent_app_type] => utility
[patent_app_number] => 13/830899
[patent_app_country] => US
[patent_app_date] => 2013-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 55
[patent_no_of_words] => 40567
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13830899
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/830899 | Antibody drug conjugates (ADC) that bind to 191P4D12 proteins | Mar 13, 2013 | Issued |
Array
(
[id] => 8927540
[patent_doc_number] => 20130183300
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-18
[patent_title] => 'METHOD TO IDENTIFY A PATIENT WITH AN INCREASED LIKELIHOOD OF RESPONDING TO AN ANTI-CANCER THERAPY'
[patent_app_type] => utility
[patent_app_number] => 13/801404
[patent_app_country] => US
[patent_app_date] => 2013-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 35870
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13801404
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/801404 | METHOD TO IDENTIFY A PATIENT WITH AN INCREASED LIKELIHOOD OF RESPONDING TO AN ANTI-CANCER THERAPY | Mar 12, 2013 | Abandoned |
Array
(
[id] => 9041120
[patent_doc_number] => 20130243758
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-19
[patent_title] => 'METHOD TO IDENTIFY A PATIENT WITH AN INCREASED LIKELIHOOD OF RESPONDING TO AN ANTI-CANCER THERAPY'
[patent_app_type] => utility
[patent_app_number] => 13/801360
[patent_app_country] => US
[patent_app_date] => 2013-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 35872
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13801360
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/801360 | METHOD TO IDENTIFY A PATIENT WITH AN INCREASED LIKELIHOOD OF RESPONDING TO AN ANTI-CANCER THERAPY | Mar 12, 2013 | Abandoned |
Array
(
[id] => 9823104
[patent_doc_number] => 08932589
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-01-13
[patent_title] => 'Methods and compositions using Kloto-FGF23 fusion polypeptides'
[patent_app_type] => utility
[patent_app_number] => 13/796711
[patent_app_country] => US
[patent_app_date] => 2013-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 26
[patent_no_of_words] => 27027
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13796711
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/796711 | Methods and compositions using Kloto-FGF23 fusion polypeptides | Mar 11, 2013 | Issued |
Array
(
[id] => 10262342
[patent_doc_number] => 20150147340
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-28
[patent_title] => 'THERAPEUTIC METHODS FOR PERITONEAL CARCINOMATOSIS'
[patent_app_type] => utility
[patent_app_number] => 14/389315
[patent_app_country] => US
[patent_app_date] => 2013-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 16441
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14389315
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/389315 | THERAPEUTIC METHODS FOR PERITONEAL CARCINOMATOSIS | Mar 11, 2013 | Abandoned |
Array
(
[id] => 9016313
[patent_doc_number] => 20130231277
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-05
[patent_title] => 'CHIMERIC FGF21 PROTEINS WITH ENHANCED BINDING AFFINITY FOR BETA-KLOTHO FOR THE TREATMENT OF TYPE II DIABETES, OBESITY, AND RELATED METABOLIC DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 13/784289
[patent_app_country] => US
[patent_app_date] => 2013-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 42583
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13784289
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/784289 | Chimeric FGF21 proteins with enhanced binding affinity for β-klotho for the treatment of type II diabetes, obesity, and related metabolic disorders | Mar 3, 2013 | Issued |
Array
(
[id] => 9839782
[patent_doc_number] => 20150031864
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-29
[patent_title] => 'Modified Adiponectin Polypeptides and Their Uses'
[patent_app_type] => utility
[patent_app_number] => 14/381189
[patent_app_country] => US
[patent_app_date] => 2013-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 85373
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14381189
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/381189 | Modified Adiponectin Polypeptides and Their Uses | Feb 26, 2013 | Abandoned |
Array
(
[id] => 9034844
[patent_doc_number] => 20130237481
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-12
[patent_title] => 'MODIFIED RELAXIN POLYPEPTIDES AND THEIR USES'
[patent_app_type] => utility
[patent_app_number] => 13/774349
[patent_app_country] => US
[patent_app_date] => 2013-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 123537
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13774349
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/774349 | Therapeutic uses of modified relaxin polypeptides | Feb 21, 2013 | Issued |
Array
(
[id] => 8904772
[patent_doc_number] => 20130172275
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-04
[patent_title] => 'INHIBITING BINDING OF FGF23 TO THE BINARY FGFR-KLOTHO COMPLEX FOR THE TREATMENT OF HYPOPHOSPHATEMIA'
[patent_app_type] => utility
[patent_app_number] => 13/763301
[patent_app_country] => US
[patent_app_date] => 2013-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 22562
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13763301
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/763301 | Pharmaceutical compositions including a portion of the C-terminus of FGF23 | Feb 7, 2013 | Issued |
Array
(
[id] => 8928451
[patent_doc_number] => 20130184211
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-18
[patent_title] => 'INHIBITING BINDING OF FGF23 TO THE BINARY FGFR-KLOTHO COMPLEX FOR THE TREATMENT OF HYPOPHOSPHATEMIA'
[patent_app_type] => utility
[patent_app_number] => 13/763263
[patent_app_country] => US
[patent_app_date] => 2013-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 22534
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13763263
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/763263 | Inhibiting binding of FGF23 to the binary FGFR-Klotho complex for the treatment of chronic kidney disease and symptoms and/or complications thereof | Feb 7, 2013 | Issued |
Array
(
[id] => 8927533
[patent_doc_number] => 20130183294
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-18
[patent_title] => 'METHODS OF USING FGF19 MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 13/745647
[patent_app_country] => US
[patent_app_date] => 2013-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 38111
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13745647
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/745647 | METHODS OF USING FGF19 MODULATORS | Jan 17, 2013 | Abandoned |
Array
(
[id] => 8820959
[patent_doc_number] => 20130122004
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-16
[patent_title] => 'METHODS AND COMPOSITIONS USING FGF23 VARIANT POLYPEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 13/743770
[patent_app_country] => US
[patent_app_date] => 2013-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 33759
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13743770
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/743770 | Methods and compositions using FGF23 variant polypeptides with reduced aggregation and cleavage | Jan 16, 2013 | Issued |
Array
(
[id] => 8903632
[patent_doc_number] => 20130171135
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-04
[patent_title] => 'METHOD TO IDENTIFY A PATIENT WITH AN INCREASED LIKELIHOOD OF RESPONDING TO AN ANTI-CANCER THERAPY'
[patent_app_type] => utility
[patent_app_number] => 13/744135
[patent_app_country] => US
[patent_app_date] => 2013-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 35859
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13744135
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/744135 | METHOD TO IDENTIFY A PATIENT WITH AN INCREASED LIKELIHOOD OF RESPONDING TO AN ANTI-CANCER THERAPY | Jan 16, 2013 | Abandoned |
Array
(
[id] => 10161441
[patent_doc_number] => 09192652
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-11-24
[patent_title] => 'Use of VEGF-C agonists for inhibiting ultraviolet B-induced skin damage'
[patent_app_type] => utility
[patent_app_number] => 13/739533
[patent_app_country] => US
[patent_app_date] => 2013-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 16486
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13739533
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/739533 | Use of VEGF-C agonists for inhibiting ultraviolet B-induced skin damage | Jan 10, 2013 | Issued |
Array
(
[id] => 9192238
[patent_doc_number] => 20130331553
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-12
[patent_title] => 'HUMAN TOLL HOMOLOGUES'
[patent_app_type] => utility
[patent_app_number] => 13/734261
[patent_app_country] => US
[patent_app_date] => 2013-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 28060
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13734261
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/734261 | HUMAN TOLL HOMOLOGUES | Jan 3, 2013 | Abandoned |
Array
(
[id] => 9427629
[patent_doc_number] => 08703704
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-04-22
[patent_title] => 'Method for growing, restoring and regenerating hair'
[patent_app_type] => utility
[patent_app_number] => 13/711925
[patent_app_country] => US
[patent_app_date] => 2012-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 7597
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13711925
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/711925 | Method for growing, restoring and regenerating hair | Dec 11, 2012 | Issued |
Array
(
[id] => 8950095
[patent_doc_number] => 20130195875
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-01
[patent_title] => 'ANTI-ADRENOMEDULLIN (ADM) ANTIBODY OR ANTI-ADM ANTIBODY FRAGMENT OR AN ANTI-ADM NON-IG SCAFFOLD FOR USE IN THERAPY'
[patent_app_type] => utility
[patent_app_number] => 13/679294
[patent_app_country] => US
[patent_app_date] => 2012-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 29424
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13679294
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/679294 | Anti-adrenomedullin (ADM) antibody or anti-ADM antibody fragment for use in therapy | Nov 15, 2012 | Issued |
Array
(
[id] => 11793209
[patent_doc_number] => 09402900
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-08-02
[patent_title] => 'Methods of modulating adrenomedullin by administering an anti-adrenomedullin (ADM) antibody'
[patent_app_type] => utility
[patent_app_number] => 14/358506
[patent_app_country] => US
[patent_app_date] => 2012-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 37
[patent_no_of_words] => 30553
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14358506
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/358506 | Methods of modulating adrenomedullin by administering an anti-adrenomedullin (ADM) antibody | Nov 15, 2012 | Issued |